2014 ( ) C172 2014 ( ) 1 1....C186 2 2....C188 3....C188 4. 2 ( )...C188 5. ( )...C192 6. 4B...C194 4B....C194 7. 5 ( )...C196 8. 8 ( )...C196 9. 9 ( )...C198 10. 10 ( )...C198 11. 10A ( )...C198
2014 ( ) C174 12. 11 ( )...C198 13. 13 ( )...C200 14. 15 ( )...C202 15. 16 ( )...C206 16. 16A ( )...C214 17. 17 ( )...C216 18. 19 ( )...C216 19. 22 ( I )...C218 20. 25 ( )...C218 21. 27 ( )...C222 22. 28A...C224 28A....C224 23. 29 ( )...C226 24. 29A...C236 29A....C238 25. 30 ( )...C238 26. 31 ( )...C238
2014 ( ) C176 27. 32 ( )...C240 28. 33 ( )...C240 29. 34 ( )...C240 30. 34A...C240 34A....C242 31....C244 32. 2 ( )...C244 33. 2A...C244 2A....C244 34. ( 22 1)...C246 35. 5 ( 22 )...C246 36. 8 ( 2 )...C246 37. 15...C246 15. Poison 5...C248
2014 ( ) C178 38. 19 ( )...C248 39. 22 ( )...C250 40. 23 ( )...C250 41. 24 ( )...C252 42. 24A ( 25 )...C252 43. 24B ( 13 )...C252 44. 24C ( 13 )...C252 45. 25...C252 25....C254 46. 26 ( ( ) )...C254 47. 27 ( )...C260 48. 28 ( )...C262 49. 28A...C268 28A....C270 50. 29 ( )...C272
2014 ( ) C180 51. 30 ( )...C278 52. 30A 30F...C278 30A....C278 30B....C280 30C....C282 30D....C284 30E....C284 30F....C286 53. 31 ( )...C290 54. 32 ( )...C294 55. 33 ( )...C294 56. 34 ( )...C298 57. 35 ( )...C300 58. 36 ( )...C302 59. 36B ( )...C308
2014 ( ) C182 60. 37 ( )...C312 61. VIIIA ( )...C316 62. 38B...C316 38B....C316 63. 39 ( )...C316 64. 41 ( )...C318 65. 1( 3 5 6 15 19 22 23 24 )...C320 66. 3...C364 67. 5 ( 27(c) 15 )...C408 68. 8...C410 69. 9 ( )...C414 70. 10...C416 10...C416 4 71....C532
2014 ( ) C184 5 72....C534...C536
201 4 ( ) C186 1 1 2009 12 1. 1 (1) 2014 ( ) (2)
201 4 ( ) C188 2 2 2. 2 ( 138 ) 3 30 3. 4. 2 ( ) (1) 2(1) (2) 2(1) (a) ( )
201 4 ( ) C190 2 4 (b) (3) 2(1) (a) (b) (i) (ii) (4) 2(1) 29 (5) 2(1) Tribunal (6) 2(1) (code of conduct) 4B
201 4 ( ) C192 2 5 (wholesale dealer licence) 29 (court) (licensed wholesale dealer) (licensed manufacturer) 29 (specified form) 29A (code of practice) 4B (7) 2(1) (1A) (1) (packaging) ( ) 5. ( ) (1) 3(2) (d) (d) (2) 3(2)(g)
201 4 ( ) C194 2 6 ) ) (3) 3(2)(h) (4) 3(2) (i) 6. 4B 4A 4B. (1) (2) (a) (b)
201 4 ( ) C196 2 7 (3) (a) (b) (4) (5) (a) (b) (6) (7) (3) (5) (8) 7. 5 ( ) 5(2) 8. 8 ( ) 8(3) (c)
201 4 ( ) C198 2 9 (c) 9. 9 ( ) 9(1) 10. 10 ( ) 10(1) 11. 10A ( ) 10A(2) (2A) 12. 11 ( ) 11 (1)
201 4 ( ) C200 2 1 3 (1) 16 ( ) 13. 13 ( ) (1) 13(2) (2) 13(4) (4A) (4)(a) (a) 16(2)(b)(i) (b) (3) 13(5)(a) (4) 13(7)(b)
201 4 ( ) C202 2 1 4 (5) 13(7)(b) (c) (6) 13(7) (7A) (7B) 14. 15 ( ) (1) 15 (1) (1A) (2) 15(1A) (1) (a)
201 4 ( ) C204 2 1 4 (b) (c) (a) (b) (i) ( 134 ) ( 137 ) ( ) ( 231 ) (ii) ( 132 ) 52 54 61 ( 362 ) 7 7A 9 (d) 13 (e) (a) (b) (3) 15(1A) (1A)
201 4 ( ) C206 2 1 5 15. 16 ( ) (1) 16(1) (2) 16(1) or which (3) 16(2)(a) (4) 16(2)(a)(i) (5) 16(2)(a)(i) (ia) (6) 16(2)(a)(ii) (5) (7) 16(2)(b)
201 4 ( ) C208 2 1 5 (8) 16(2)(b)(i) (9) 16(2)(b)(ii) (ii) 13(5) (10) 16(2)(b)(ii) (11) 16(2)(b)(ii) (iia)
201 4 ( ) C210 2 1 5 (12) 16(2)(b)(iii) (13) 16(2) (2A) (2B) (2C) (2) (a) (b) (i) (3) (A) (3)(a) (B) 3 (ii) (3) (2B) (2)(a)(ii) (b)(i) (ii) ( )
201 4 ( ) C212 2 1 5 (2C) (2B) (a) (3)(a) (b) 3 (14) 16(3)(a) (2) (2) (2C) (15) 16(3)(b) (16) 16(4) (2) ( )
201 4 ( ) C214 2 1 6 (17) 16 (5) (18) 16(6) (19) 16(6)(b) (20) 16(7) (5) (2A) 16. 16A ( ) (1) 16A(3) $500 (2) 16A(5)
201 4 ( ) C216 2 1 7 $500 17. 17 ( ) 17(2)(d) ( 134 ) ( 137 ) 15(1)(c) 18. 19 ( ) (1) 19 (2) 19(1) (3) 19(1)
201 4 ( ) C218 2 1 9 (4) 19 (2) 19. 22 ( I ) (1) 22(1)(a) (2) 22(2) (3) 22(4) $5,000 2 20. 25 ( ) (1) 25(2) (2A) (2B) (2C)
201 4 ( ) C220 2 20 (a) (b) (2) 25(3) (3) 25(3) (2A) (4) 25(3) (5) 25(3) (6) 25(3) (3A) (2A)
201 4 ( ) C222 2 21 (a) (b) (3B) (3) 3 ( ) (7) 25(5) (2A) (3) (3A) 21. 27 ( ) 27 (c) (c) () (ca)
201 4 ( ) C224 2 22 (i) (ii) ( ) Poison 22. 28A 28A 28A. (1) (a) (b) (2) (a) (b) (3) (a) ( 2014 ( ) (2014 ) () )
201 4 ( ) C226 2 23 (b) 22 23. 29 ( ) (1) 29(1)(aa) (2) 29(1)(b) (3) 29(1)(c) (4) 29(1)(ca)
201 4 ( ) C228 2 23 (5) 29(1) (f) (f) 22(1)(a) (6) 29(1) (g) (7) 29(1)(h) (8) 29(1)(ha) (9) 29(1)(j)
201 4 ( ) C230 2 23 (ja)(ii) (10) 29(1)(ja) (i) (ii) (11) 29(1)(ja) (jb) (ja)(i)
201 4 ( ) C232 2 23 (jc) (ja)(i) (12) 29(1)(k) (13) 29(1)(m) (14) 29(1)(q) ( ) (15) 29(1)(q)
201 4 ( ) C234 2 23 (16) 29(1)(qa) (17) 29(1) (qb) (qb) (18) 29(1)(r)
201 4 ( ) C236 2 24 (19) 29(1)(r) (s) (t) (u) (v) (20) 29(1A) (1B) (1) 31 (a) (b) (1) (i) (ii) 24. 29A 29
201 4 ( ) C238 2 25 29A. (1) (2) (a) (b) 25. 30 ( ) (1) 30(1)(aa) 25(3) 25(2A) (3) (3A) (2) 30(1)(aa) (ab) 29 26. 31 ( ) (1) 31(1) (2) 31(1)(a)
201 4 ( ) C240 2 27 (i) 27. 32 ( ) 32 (b) (b) 28A(2) 28. 33 ( ) 33(1) 28 28 28A 29. 34 ( ) 34 $100,000 6 30. 34A 34
201 4 ( ) C242 2 30 34A. (1) (2) (1)
201 4 ( ) C244 31 31. ( 138 A) 32 70 32. 2 ( ) 2(1) (specified form) 38B (GMP Guide) 28A (authorized person) (register of authorized persons) 30B 33. 2A 2 2A. 10
201 4 ( ) C246 34 34. ( 22 1) ( 138 B) 35. 5 ( 22 ) (1) 5(1) (2) 5(5) $10,000 36. 8 ( 2 ) 8(2) VII VIII VIIIA VI VII VIII 37. 15 15
201 4 ( ) C248 38 15. Poison 5 (1) 27(c) 5 (2) 27(ca) (a) 5 (b) Poison (3) (1) (2) 38. 19 ( ) (1) 19(2) 1 I (2) 19(2)
201 4 ( ) C250 39 (3) 19(3) 39. 22 ( ) (1) 22(4)(a) (2) 22(4) (b) (3) 22(5) 40. 23 ( ) 23(3)
201 4 ( ) C252 41 41. 24 ( ) (1) 24(2)(b) (2) 24 (3) (3) 24 (4) 42. 24A ( 25 ) 24A(4) 43. 24B ( 13 ) 24B (a) 44. 24C ( 13 ) 24C 45. 25 25
201 4 ( ) C254 46 25. ( ) (a) (b) (c) 46. 26 ( ( ) ) (1) 26(3) (2) 26(4)
201 4 ( ) C256 46 (3) 26(4) (4) 26 (5) (5) (5A) (a) (b) (c) (3) (5A) (a) (i) (ii) (b) (i) 29 ( 134 )( 137 ) ( ) ( 231 )
201 4 ( ) C258 46 (ii) ( 60 ) 6C 6D ( 132 ) 52 54 61 ( 362 ) 7 7A 9 (5B) (5)(a) 3 ( ) (5) 26(6) (3) (5) (6) 26(8) (7) 26(8)(a)
201 4 ( ) C260 47 (8) 26(8)(b) (9) 26(9) (10) 26(9) (10) (a) ( 2014 ( ) (2014 ) () ) (b) 46 29 47. 27 ( ) (1) 27
201 4 ( ) C262 48 (2) 27 (a) (3) 27 (a) (a) (ab) (4) 27 (j) (j) II 48. 28 ( ) (1) 28
201 4 ( ) C264 48 (2) 28(1) (1) ( ) I (3) 28(1)(c) (4) 28(1)(c) (ca) ( ) ( ) (5) 28(1)(d) (6) 28(2) (2) ( ) I
201 4 ( ) C266 48 (7) 28(2)(c) (8) 28(2)(d) (9) 28(2)(f) (10) 28(2)(f) (fa) ( ) ( ) (11) 28(2)(g) (12) 28(3) (3) I (13) 28(3)
201 4 ( ) C268 49 (14) 28(4) (15) 28(7) (16) 28(8) (8) 49. 28A VII 29
201 4 ( ) C270 49 28A. (1) (2) (a) (b) (3) (a) (b) (4) (5) (a) (b) (6)
201 4 ( ) C272 50 (7) (3) (5) 50. 29 ( ) (1) 29(1) (2) (2) 29(1) (1A) (1) (3) 29 (a) (i) 31(1)(a) (b) (e) (f) (ii) (iii) (b) (2) (i) (a) (ii) 31(1)(c)
201 4 ( ) C274 50 (4) 29(3) (5) 29 (4) (4) (4A) (a) (b) (c) (3) (4A) (a) (i) (ii) (b) (i) 29 ( 134 )(
201 4 ( ) C276 50 137 ) ( ) ( 231 ) (ii) ( 60 ) 6C 6D ( 132 ) 52 54 61 ( 362 ) 7 7A 9 (4B) (4)(a) 3 ( ) (6) 29(5) (a) (b) (7) 29(6) (8) 29(6)
201 4 ( ) C278 51 (a) (b) (9) 29(7) 51. 30 ( ) (1) 30(1)(a) (2) 30(1) (b) 52. 30A 30F 30 30A. (1) (2)
201 4 ( ) C280 52 (2) (a) (b) (3) (registered particulars) 35A (registrable particulars) 35A 30B. (1) (2) (3) (a) (b) (4)
201 4 ( ) C282 52 (5) 30C. (1) (2) (2) (a) (i) (ii) (b) (i) 3 (ii) (3) (4)
201 4 ( ) C284 52 30D. (1) 30C (2) (3) (4) 9 (5) 30F (6) 30E. (1) (2) (3) (4)
201 4 ( ) C286 52 (5) 9 (6) 30F (7) 30F. (1) (2) (a) (b) (c) (d) 30D(3) 30E(4) (2) (a) (b) (i)
201 4 ( ) C288 52 (ii) (c) (i) 29 ( 134 )( 137 ) ( ) ( 231 ) (ii) ( 132 ) 52 54 61 ( 362 ) 7 7A 9 (3) (1)(a) (b) 3 ( ) (4) (a) (1)(a) (b) (1)(b)
201 4 ( ) C290 53 (5) 30D 30E (6) (1) 53. 31 ( ) (1) 31 (2) 31(1) (3) 31(1)(c) (4) 31(1)(d)
201 4 ( ) C292 53 (5) 31(1)(d) (e) (f) (6) 31(2)(b)(ii) (7) 31(2)(b) (c) (batch number) (i) (ii) (d) (expiry date) 36(3)(a)(ii) (8) 31(3)
201 4 ( ) C294 54 54. 32 ( ) (1) 32 (2) 32 55. 33 ( ) (1) 33 (2) 33(1) (3) 33(1A)
201 4 ( ) C296 55 (4) 33 (2) (2) (5) 33(4) (6) 33(4) 1 (7) 33(5) (8) 33(5)
201 4 ( ) C298 56 (6) (expiry date) 31(2)(d) (registered particulars) 35A (registrable particulars) 35A 56. 34 ( ) (1) 34 (2) 34(1) (3) 34(1)(b) (4) 34(2) (5) 34(5)
201 4 ( ) C300 57 57. 35 ( ) (1) 35 (2) 35(1) (3) 35 (2) (2) (1)(a) (b) (d) (e) (g) (3) (1)(c) 72 (4) (1)(f) (a) 72 (b) 72
201 4 ( ) C302 58 58. 36 ( ) (1) 36(1) (2) 36(1)(a) (3) 36(1)(b) 28A(1) (3) (4) 36(1)(c) (5) 36(1A)(a)(i)
201 4 ( ) C304 58 (6) 36(1A)(a) (ii) (ii) (7) 36(1A)(a) (iii) (8) 36(1A)(a) (ab) (9) 36(1A)(b) (10) 36(1A)(b) (c) ( 36B(3) ) (d) ( 36B(3) )
201 4 ( ) C306 58 (11) 36(2) 8 (12) 36(2) ( 8 6) (13) 36(5) (14) 36(5) ( 8 7) (15) 36 (7) (7) (5) (a) 9
201 4 ( ) C308 59 (b) (16) 36(7) (7A) (7) (7B) (5) (7A) (17) 36(8) (18) 36(9) 59. 36B ( ) (1) 36B (1) (1C) (2) 36B(1C)
201 4 ( ) C310 59 (1) (3) (1A) (3) (1B) (1) (1A) 2 (3) 36B(2) (4) 36B(3) 5 (5) 36B(3) ( 8 12) (6) 36B(3) (3A) (3)
201 4 ( ) C312 60 (3B) (a) (b) (3C) (1C) (3D) (3B) ( ) (7) 36B(4) 60. 37 ( ) (1) 37(3)
201 4 ( ) C314 60 (2) 37(3) (3) 37(3)(a) (4) 37(3)(b) (5) 37(3)(b) (6) 37(3)(b) (c) (a)
201 4 ( ) C316 61 61. VIIIA ( ) VIIIA 62. 38B X 39 38B. (1) 4A (2) (a) (b) 63. 39 ( ) (1) 39(d) (2) 39(e) (3) 39
201 4 ( ) C318 64 64. 41 ( ) (1) 41 (2) 41(1) (3) 41 (2) (4) 41(2A) (5) 41 (3)
201 4 ( ) C320 65 65. 1 ( 3 5 6 15 19 22 23 24 ) (1) 1 15 19 22 23 22 (2) 1 [ 5(1) 6 7 15(3) 17(3) 19(2) 22(3) 23(3)(b) 24(2)(b) (4) ] [ 3 5 6 7 17 22 24 5] (3) 1 A (4) 1 A Antisera, antitoxins, immunoglobulins and vaccines (a) Bacillus Calmette-Guerin Bacillus Calmette-Guérin (5) 1 A Antisera, antitoxins, immunoglobulins and vaccines (b)
201 4 ( ) C322 65 (a) Japanese encephalitis (b) Japanese encephalitis (6) 1A Atracurium Besylate Besylate besylate (7) 1A (a) Benzquinamide (b) Benzoylmorphine; its salts Benzquinamide (8) 1 A Contrast media Sulphur Hexafluoride Sulphur hexafluoride (9) 1 A Dihydrallazine; its salts Dihydrallazine Dihydralazine (10) 1 A Foscarnet Trisodium Hexahydrate
201 4 ( ) C324 65 Trisodium Hexahydrate trisodium hexahydrate (11) 1A Guanidines Polymethylene diguanidines; di-para-anisyl-paraphenetylguanidine; Polymethylene diguanidines; di-para-anisyl-paraphenethylguanidine; (12) 1 A Haloperidol and other 4-substituted derivatives of N-(3-parafluorobenzoyl-propyl) piperidine N-(3-parafluorobenzoyl-propyl) N-(3-para-fluorobenzoylpropyl) (13) 1A Hydiazines Hydiazines Hydrazines (14) 1A (a) Hydrallazine; its salts (b) Hexobendine; its salts
201 4 ( ) C326 65 Hydralazine; its salts (15) 1A Ketanserine; its salts Ketanserine Ketanserin (16) 1A Ketoconazole Ketoconazole Ketoconazole, (17) 1A Lithium Sulphate Sulphate sulphate (18) 1A (a) Meclobemide; its salts (b) Mizolastine; its salts Moclobemide; its salts (19) 1 A Meclofenamic Acid; its salts
201 4 ( ) C328 65 Acid acid (20) 1 A (21) 1 A 2-Methyl-3-morpholino- 1,1-diphenylpropanecarboxylic acid 1-diphenylpropanecarboxylic 1-diphenylpropane carboxylic (22) 1A Minoxidil Minoxidil except Minoxidil, except (23) 1 A Niflumic Acid; its salts Acid acid
201 4 ( ) C330 65 (24) 1A Piroxicam Piroxicam Piroxicam, (25) 1A Salbutamol and its salts salts salts, (26) 1 A (27) 1A Tetracosatrin; its salts Tetracosatrin Tetracosactide (28) 1 A Tolfenamic Acid; its salts Acid acid
201 4 ( ) C332 65 (29) 1 A Tranexamic acid acid acid, (30) 1A (a) Vencuronium; its salts (b) Vasopressins Vecuronium; its salts (31) 1 A (32) 1A (a) (b) (33) 1A
201 4 ( ) C334 65 (34) 1A (35) 1A (36) 1A (37) 1A (a) (b) (38) 1A
201 4 ( ) C336 65 (39) 1A (40) 1A (a) (b) (41) 1A -1-1 4- -1 4- ( ) (42) 1A
201 4 ( ) C338 65 (43) 1A (44) 1A (45) 1A (b) (46) 1A (47) 1A
201 4 ( ) C340 65 (48) 1A (49) 1A (a) (b) (50) 1A ( ) (51) 1A (a) (b) (52) 1A 0.2%
201 4 ( ) C342 65 (53) 1A (54) 1A (55) 1A (56) 1A (57) 1A (58) 1A (a)
201 4 ( ) C344 65 (b) (59) 1A (60) 1A ( ) N-(3- ) 4 (61) 1A ( F 2 a) ( F 2 ) (62) 1A (a) Bimatoprost (b) (63) 1A
201 4 ( ) C346 65 (a) Travoprost (b) (64) 1A (a) Unoprostone (b) (65) 1A (66) 1A (67) 1A (68) 1A
201 4 ( ) C348 65 (69) 1A (70) 1A a1 a (71) 1A (a) 6- (b) 6- (72) 1A (a) (b)
201 4 ( ) C350 65 (73) 1A (a) (b) (74) 1A (75) 1A (a) (b) (76) 1A (a) (b) (77) 1A (78) 1A (a)
201 4 ( ) C352 65 (b) (79) 1A (a) Anagrelide (b) (80) 1A (a) Brinzolamide (b) (81) 1A (a) Candesartan (b) (82) 1A (a) Celecoxib (b) (83) 1A (a) Cidofovir
201 4 ( ) C354 65 (b) (84) 1A (a) Darbepoetin alfa (b) (85) 1A (a) Eletriptan (b) (86) 1A (a) Eprosartan (b) (87) 1A (a) Eptifibatide (b) (88) 1A (a) Etanercept (b)
201 4 ( ) C356 65 (89) 1A (a) Fondaparinux (b) ( ) ( ) (90) 1A (a) Ibandronic acid (b) (91) 1A (a) Imatinib (b) (92) 1A (a) Imiglucerase (b) (93) 1A (a) Indinavir (b)
201 4 ( ) C358 65 (94) 1A (a) Lepirudin (b) (95) 1A (a) Levosimendan (b) (96) 1A (a) Mangafodipir (b) (97) 1A (a) Metaflumizone (b) (98) 1A (a) Palivizumab (b)
201 4 ( ) C360 65 (99) 1A (a) Pimecrolimus (b) (100) 1A (a) Rasburicase (b) (101) 1A (a) Ritonavir (b) (102) 1A (a) Sevelamer (b) (103) 1A (a) Stavudine (b) ( ) (104) 1A (a) Tadalafil
201 4 ( ) C362 65 (b) 6-(5- [1,3] )-2,3,6,7,12,12a- [1,2 :1,6] [3,4-b] -1,4- ( ) (105) 1A (a) Tenecteplase (b) (106) 1A (a) Topotecan (b) (107) 1A (a) Ustekinumab (b) (108) 1A (a) Valganciclovir (b) (109) 1A
201 4 ( ) C364 66 (a) Verteporfin (b) (110) 1A (a) Voriconazole (b) (111) 1A (a) Ziprasidone (b) (112) 1B 66. 3 (1) 3 [ 9(1) ] [ 9 5 10]
201 4 ( ) C366 66 (2) 3 A (3) A Antisera, antitoxins, immunoglobulins and vaccines (a) Bacillus Calmette-Guerin Bacillus Calmette-Guérin (4) A Antisera, antitoxins, immunoglobulins and vaccines (b) (a) Japanese encephalitis (b) Japanese encephalitis (5) 3A Atracurium Besylate Besylate besylate (6) A Contrast media
201 4 ( ) C368 66 Sulphur Hexafluoride Sulphur hexafluoride (7) 3A (a) 3-(3,4-Dihydroxyphenyl)alanine; its salts (b) Dihydroetorphine; its salts 3-(3,4-Dihydroxyphenyl)alanine; its salts (8) A Dihydrallazine; its salts Dihydrallazine Dihydralazine (9) A Foscarnet Trisodium Hexahydrate Trisodium Hexahydrate trisodium hexahydrate (10) A Haloperidol and other 4-substituted derivatives of N-(3-para-fluoro-benzoyl-propyl) piperidine N-(3-para-fluoro-benzoyl-propyl) N-(3-para-fluorobenzoylpropyl)
201 4 ( ) C370 66 (11) 3A Hydrallazine; its salts Hydrallazine Hydralazine (12) 3A Ketanserine; its salts Ketanserine Ketanserin (13) 3A Ketoconazole Ketoconazole Ketoconazole, (14) 3A Lithium Sulphate Sulphate sulphate (15) 3A (a) Meclobemide; its salts (b) Mizolastine; its salts
201 4 ( ) C372 66 Moclobemide; its salts (16) 3A Minoxidil Minoxidil except Minoxidil, except (17) 3A Piroxicam Piroxicam Piroxicam, (18) 3A Salbutamol and its salts salts salts, (19) 3 A (20) 3A Tetracosatrin; its salts Tetracosatrin
201 4 ( ) C374 66 Tetracosactide (21) A Tranexamic acid acid acid, (22) 3A (a) Vencuronium; its salts (b) Vasopressins Vecuronium; its salts (23) 3 A (24) 3A (a) (b) (25) 3A
201 4 ( ) C376 66 (26) 3A (27) 3A (28) 3A (29) 3A (30) 3A (a)
201 4 ( ) C378 66 (b) (31) 3A (32) 3A (33) 3A (a) (b) (34) 3A -1-1 4- -1 4- ( )
201 4 ( ) C380 66 (35) 3A (36) 3A (37) 3A (38) 3A (b) (39) 3A
201 4 ( ) C382 66 (40) 3A (41) 3A (42) 3A (a) (b) (43) 3A (a) (b) (44) 3A A
201 4 ( ) C384 66 (45) 3A (46) 3A (47) 3A (48) 3A (49) 3A ( )
201 4 ( ) C386 66 (50) 3A (51) 3A (a) (b) (52) 3A (53) 3A ( F 2a ) ( F 2 ) (54) 3A (a) Bimatoprost
201 4 ( ) C388 66 (b) (55) 3A (a) Travoprost (b) (56) 3A (a) Unoprostone (b) (57) 3A (58) 3A (a) (b) (59) 3A
201 4 ( ) C390 66 (60) 3A (61) 3A (62) 3A a1 a (63) 3A (a) 6- (b) 6- (64) 3A (a)
201 4 ( ) C392 66 (b) (65) 3A (66) 3A (67) 3A (a) (b) (68) 3A (a) (b) (69) 3A (a)
201 4 ( ) C394 66 (b) (70) 3A (71) 3A (72) 3A (a) (b) (73) 3A (a) Anagrelide (b) (74) 3A
201 4 ( ) C396 66 (a) Brinzolamide (b) (75) 3A (a) Candesartan (b) (76) 3A (a) Celecoxib (b) (77) 3A (a) Cidofovir (b) (78) 3A (a) Darbepoetin alfa (b) (79) 3A
201 4 ( ) C398 66 (a) Eletriptan (b) (80) 3A (a) Eprosartan (b) (81) 3A (a) Eptifibatide (b) (82) 3A (a) Etanercept (b) (83) 3A (a) Fondaparinux (b) ( ) ( ) (84) 3A (a) Ibandronic acid (b)
201 4 ( ) C400 66 (85) 3A (a) Imatinib (b) (86) 3A (a) Imiglucerase (b) (87) 3A (a) Indinavir (b) (88) 3A (a) Lepirudin (b) (89) 3A (a) Levosimendan (b)
201 4 ( ) C402 66 (90) 3A (a) Mangafodipir (b) (91) 3A (a) Metaflumizone (b) (92) 3A (a) Palivizumab (b) (93) 3A (a) Pimecrolimus (b) (94) 3A (a) Rasburicase (b)
201 4 ( ) C404 66 (95) 3A (a) Ritonavir (b) (96) 3A (a) Sevelamer (b) (97) 3A (a) Stavudine (b) ( ) (98) 3A (a) Tadalafil (b) 6-(5- [1,3] )-2,3,6,7,12,12a- [1,2 :1,6] [3,4-b] -1,4- ( ) (99) 3A (a) Tenecteplase (b)
201 4 ( ) C406 66 (100) 3A (a) Topotecan (b) (101) 3A (a) Ustekinumab (b) (102) 3A (a) Valganciclovir (b) (103) 3A (a) Verteporfin (b) (104) 3A (a) Voriconazole (b)
201 4 ( ) C408 67 (105) 3A (a) Ziprasidone (b) (106) 3 A (a) (b) (c) (d) 67. 5 ( 27(c) 15 ) (1) 5 27(c) 15 27(c) (ca) 15 (2) 5 [ 15(2) ] [ 15 ]
201 4 ( ) C410 67 (3) 5 (a) 1 (b) 2 (c) 3 (d) 4 (e) 5 (f) 6 (g) 7 (h) 8 (i) 9 (j) 10 words text (4) 5 12. Prescription Drug 3 13. Drug under Supervised Sales I
201 4 ( ) C412 68 68. 8 (1) 8 (a) 1 (b) 2 (c) 3 (d) 4 (e) 5 (f) 5A (g) 6 (h) 7 (i) 8 (j) 9 (k) 10 (l) 12 (m) 13 (n) 14 (o) 15 (p) 16 (2) 8 17
201 4 ( ) C414 69 17 [ 41 ] 13A 69. 9 ( ) (1) 9 [ 26 29 36 36B 36D 37A 41 ] [ 24A 26 29 30D 30E 36 36B 36D 41 ] (2) 9 5 (3) 9 9
201 4 ( ) C416 70 ( ) (4) 9 10 10A. 1,420 10B. 1,420 (5) 9 20 70. 10 9 1. 10 [ 2A ] (1) (a) (b) (2) (derivative) (a) ( )
201 4 ( ) C418 70 (i) (ii) (b) ( ) (c) (3) (a) A (b) B 2. I A ( ) ( )
201 4 ( ) C420 70 ( )
201 4 ( ) C422 70 3-(3 4- ) 2 2 2-3-
201 4 ( ) C424 70
201 4 ( ) C426 70 6-(5- [1,3] )-2,3,6,7,12,12a- [1,2 :1,6] [3,4-b] -1,4- ( ) ( )
201 4 ( ) C428 70
201 4 ( ) C430 70 ( )
201 4 ( ) C432 70 ( )
201 4 ( ) C434 70 ( ) ( ) ( (a) 4 (b) ) ( )
201 4 ( ) C436 70 1--4--4-2--3- -1 1-
201 4 ( ) C438 70 ( ) 2-(2- )-5--7- [5,1-f ][1,2,4] -4(3H )- ( )
201 4 ( ) C440 70
201 4 ( ) C442 70-1 4- ( )
201 4 ( ) C444 70 ( )
201 4 ( ) C446 70 1-[1-(4- ) ]-3- -1- ( )
201 4 ( ) C448 70
201 4 ( ) C450 70
201 4 ( ) C452 70 ( ( ) ) ( ) ( ) (a)
201 4 ( ) C454 70 (b)
201 4 ( ) C456 70 Feline calicivirus Feline Chlamydia psittaci Feline immunodeficiency virus Feline leukemia virus Feline panleukopenia virus Feline rhinotracheitis virus 3- -4 5 6-
201 4 ( ) C458 70 ( ) 1 2
201 4 ( ) C460 70 (2- ) 2- ( )
201 4 ( ) C462 70
201 4 ( ) C464 70 ( )
201 4 ( ) C466 70 5-(2- )-1--3--1H- [4,3-d ] -7(6H)- ( ) ( )
201 4 ( ) C468 70
201 4 ( ) C470 70
201 4 ( ) C472 70 ( ) ( ) ( ) N
201 4 ( ) C474 70 A A ( )
201 4 ( ) C476 70 ( ) ( F 2 ) ( E2)
201 4 ( ) C478 70 G ( ) ( ) ( ) ( ) N-(3- ) 4
201 4 ( ) C480 70 ( )
201 4 ( ) C482 70 - - (2 4 6- ) ( ) 4--4-5- (5- )
201 4 ( ) C484 70 ( 1 2 ) 60% ( ) 60% ( ) ( )
201 4 ( ) C486 70 ( ) ( ( 137 ) )
201 4 ( ) C488 70 1%
201 4 ( ) C490 70 ( ) 1 ( ) ( )
201 4 ( ) C492 70 ( ) A -CD3
201 4 ( ) C494 70
201 4 ( ) C496 70 ( )
201 4 ( ) C498 70 ( )
201 4 ( ) C500 70 N
201 4 ( ) C502 70 9-1 1- -1 2 4- -7-
201 4 ( ) C504 70 4--1--4-4--2--4 4- ( )
201 4 ( ) C506 70 ( ) ( )
201 4 ( ) C508 70
201 4 ( ) C510 70 ( ) 200 6-
201 4 ( ) C512 70 5- ( ) -N N- 3--N- 3--N- ( ) 3- ( )
201 4 ( ) C514 70 ( ) ( ) ( )
201 4 ( ) C516 70 A 10 000 A A ( ) ( ) ( ) ( )
201 4 ( ) C518 70 A ( ) ( ) ( )
201 4 ( ) C520 70 ( ) N-[4 4- ] 4
201 4 ( ) C522 70 Antilymphocyte Immunoglobulins Dermatophagoides pteronyssinus Drotrecogin alfa Inosine pranobex Melatonin Phenprenazone Poractant alfa Strontium ranelate B
201 4 ( ) C524 70 (a) 0.1% (b) (i) 0.1% (ii) 2% (iii) 0.75% ( ) (3- -1 2- ) 70% ( ) II II A 60% ( ) I 60% ( ) I
201 4 ( ) C526 70 1% I A (a) ( ) 0.01% (b) 2% (c) 0.1% (i) 3 (ii)
201 4 ( ) C528 70 6- ( )(a) 4 (b)
201 4 ( ) C530 70 B γ ( ) I B 0.1%
201 4 ( ) C532 4 71 4 71. ( 138 B)
201 4 ( ) C534 5 72 5 72. (1) (2)
201 4 ( ) C536 1 1 1. 1 1 2. 2 3 3. 5 [ 72 ] 1 ( 138 ) 1 2
201 4 ( ) C538 1 4 4. 4 11 5. 5 15 4 5 6. 6 21
201 4 ( ) C540 2 9 7. 7 28A 8. 8 29 6 7 8 2 ( 138 A) 9. III ( ) III
201 4 ( ) C542 2 1 0 10. 18 ( ) 18 11. IV ( ) IV 12. VB ( ) VB 13. VI ( ) VI 14. VII ( ) VII
201 4 ( ) C544 1 2009 12 ( 138 ) () ( 138 A)() ( 138 B) 2. 3. 4(2) 2(1) 29(1A) ( 50(2) ) 4. 50(3) 29(2) 5. 53 31 2 6. 55 33 55
201 4 ( ) C546 7 7. 57 35 8. 63 39 28 35 9. 29(1)(ja) ( 23(10) ) 28A ( 49 ) ( ) () 10. 23(10) (11) 29 11. 52 30A 30F 30A 30B
201 4 ( ) C548 1 2 12. 30C 30D 30E 30C 13. 30F ( ) ( ) 14. 27 I II 21 15. 67 5 16. 15 Poison 37 17. 38 19 1 I ( I ) I
201 4 ( ) C550 1 8 18. 39 40 41 22 23 24 ( ) 19. 59 36B 59 2 5 20. 59 21. 22 28A VIIIA ( 61 ) 22. 28 33(1) 28A
201 4 ( ) C552 23 23. 25 45 ( ) ( 26 ) ( 46 ) 24. 26 ( ) ( 46 ) 25. 27 47 26. 48 28 I ( ) 27. 58 36
201 4 ( ) C554 28 28. 58(8) (10) 36(1) 29. 58(15) 36(7) 30. 6 4B 31 40 31. 14 15 ( ) ( ) ( 132 ) ( 362 )
201 4 ( ) C556 32 32. 15 16 15 ( ) 33. 16 13(4)(a) 13 ( 13 ) 34. 20 25 ( ) 25 35. 20
201 4 ( ) C558 36 36. 46 26 ( ) ( ) 46 37. 46 38. 50 29 39. 50 ( ) 40. 58 36 58
201 4 ( ) C560 41 41. 5 3(2) 42. 8 8(3)(c) ( 8 ) 43. 9 11 13 19 23 9 10A 13 22 29 ( 13 ) 22(1)(a) 44. 43 29A ( 24 ) 29A 45. 46 24B 24C 26(4) 28(4) 29(3) (5) (6) 36(2) (5) 36B(3) 41(1) (2) (3) 8 ( 43 44 46(3) 48(14) 50(4) (6) (8) 58(11) (14) 59(4) (5) 64(2) (3) (5) 68 )
201 4 ( ) C562 46 46. ( 13 ) I 22(1)(a) 47. 62 38B ( 4A ) 48. 10 10(1) 34 49. 16 16A(3) (5) ( 16 ) $500 ( $10,000) 50. 19(3) 22(4) I $5,000 2 ( $5,000)
201 4 ( ) C564 51 51. 29 34 ( ) $100,000 6 ( $100,000) 52. 30 34A 53. 35(2) 5(5) I $10,000 ( $10,000) 54. 13(5) (6) 13 ( ) 55. 20(1) 25 56. 60 37(3)
201 4 ( ) C566 57 57. 69 9 58. 72 59. medicinal product ( 2001/83/EC 1 ) 2(1) ( 4(3) ) 60. 33 2A 10 10 ( 138 B) ( 71 ) 61. 23 29(1B) 29(1)
201 4 ( ) C568 62 62. 15 17 17 ( 17 ) 63. 25 30(1) ( 29 ) 64. 65 1 66 3